Crystalline (6R,7R)-7-{2-(5-Amino- [1,2,4]thiadiazol-3-yl)- 2-[(Z)-trityloxyimino]-acetylamino}-3-[(R )-1'-tert-butoxycarbonyl-2-oxo-[1,3']bipy rrolidinyl- (3E)-ylidenemethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester; its manufacture and use

Details for Australian Patent Application No. 2009237689 (hide)

Owner Basilea Pharmaceutica AG

Inventors Longoni, Davide; Heubes, Markus; Schleimer, Michael; Alpegiani, Marco; Cabri, Walter

Agent Spruson & Ferguson

Pub. Number AU-A-2009237689

PCT Pub. Number WO2009/127623

Priority 08154517.0 15.04.08 EP

Filing date 14 April 2009

Wipo publication date 22 October 2009

International Classifications

C07D 501/12 (2006.01) Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins

A61K 31/546 (2006.01) - containing further heterocyclic rings, e.g. cephalothin

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 501/54 (2006.01) Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins

Event Publications

11 November 2010 PCT application entered the National Phase

  PCT publication WO2009/127623 Priority application(s): WO2009/127623

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009237690-Blood treatment apparatus

2009237675-Spirocyclic derivatives as histone deacetylase inhibitors